Naiyer Rizvi, MD - The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
02/07/19 • 41 min
Previous Episode
Paul M. Ridker, MD, MPH, FACC, FAHA - Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis
Looking Beyond Lipids: A Visual Guide to Targeting Vascular Inflammation in Atherosclerosis
Next Episode
Gregory Piazza, MD, MS - Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/peerview-heart-lung-and-blood-cmecnecpe-video-podcast-25504/naiyer-rizvi-md-the-evolving-role-of-immunotherapy-as-a-component-of-m-4347744"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to naiyer rizvi, md - the evolving role of immunotherapy as a component of multimodal therapy in earlier stages of lung cancer: rationale, current evidence, key trials, and implications for multidisciplinary care on goodpods" style="width: 225px" /> </a>
Copy